Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02606578 · ClinicalTrials.gov registry record
Achalasia Patient Reported Outcomes
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 200
- Enrollment target
NCT02606578: Clinical Trial study, sponsored by Mayo Clinic.
NCT02606578 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02606578 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Patients that are either scheduled to undergo or have undergone an achalasia procedure at the Mayo Clinic Rochester are asked to participate. The purpose of this study is to gather information and determine if one of these procedures is superior to the other.
Primary Outcome
Comparison of surgical techniques evaluated from the patient's medical record using patient reported post-operative symptoms on the achalasia questionnaire. The achalasia questionnaire includes quality of life, pain, activity level, heart burn, acid regurgitation, reflux, dysphagia, and diet.
Interventions
- OTHER Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-10 |
| Est. Completion | 2021-01-15 |
Why NCT02606578 stopped before completion
NCT02606578 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires is the first listed.
NCT02606578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02606578 about?
NCT02606578 is a clinical study titled "Achalasia Patient Reported Outcomes". Patients that are either scheduled to undergo or have undergone an achalasia procedure at the Mayo Clinic Rochester are asked to participate. The purpose of this study is to gather information and determine if one of these procedures is superior to the other.
What is the current status of trial NCT02606578?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2015-10. Estimated completion is 2021-01-15.
What interventions are being tested in trial NCT02606578?
The interventions under investigation include: Questionnaires (OTHER).
Who is sponsoring clinical trial NCT02606578?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia